Irreversible electroporation promising in pancreatic cancer

September 4, 2015
Irreversible electroporation promising in pancreatic cancer

(HealthDay)—Irreversible electroporation (IRE) in pancreatic cancer cells may improve survival rates for some patients, new research suggests. The findings were published in the September issue of the Annals of Surgery.

Robert Martin II, M.D., Ph.D., director of at the University of Louisville in Kentucky, and colleagues included patients with locally-advanced pancreatic cancer, making complete surgical removal impossible. All of the 200 adults with stage III pancreatic cancer included in the current study underwent electrical IRE treatment after completing chemotherapy.

About half of the patients in the study experienced complications. But the side effects related to IRE were minimal, according to Martin. Any side effects were "directly related to the surgical procedure" required to make the tumor area accessible, he told HealthDay. The average survival was two years. The study authors followed some patients for as long as seven years.

"For patients with locally-advanced (stage III), the addition of IRE to conventional chemotherapy and radiation therapy results in substantially prolonged survival compared with historical controls," the authors write. "These results suggest that ablative control of the primary tumor may prolong survival."

Explore further: CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma

More information: Full Text (subscription or payment may be required)

Related Stories

CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma

May 7, 2014
A small group of patients with locally advanced unresectable pancreatic carcinoma suffered no major ill effects—pancreatitis or fistula formation—after undergoing percutaneous CT-guided irreversible electroporation (IRE)—a ...

Study finds genes associated with improved survival for pancreatic cancer patients

August 20, 2015
A study by the Translational Genomics Research Institute (TGen) and other major research institutes, found a new set of genes that can indicate improved survival after surgery for patients with pancreatic cancer. The study ...

Electrical pulse treatment gives pancreatic cancer patients new hope

March 26, 2012
Results of a study presented at the Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif., signal a light at the end of the tunnel for individuals with inoperable locally advanced pancreatic ...

Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer

September 16, 2014
For patients with locally advanced pancreatic cancer, the combination of chemotherapy and stereotactic ablative radiation (SABR) may be a promising treatment option, ultimately allowing them to undergo surgery that may not ...

Stereotactic body radiation therapy appears to help some patients with pancreatic cancer

May 18, 2015
Two studies from Johns Hopkins Kimmel Cancer Center researchers add to preliminary evidence that high-dose radiation treatment, called stereotactic body radiotherapy, appears to be safe and as effective as standard radiation ...

Intraperitoneal chemotherapy ups ovarian cancer outcomes

August 5, 2015
(HealthDay)—Intraperitoneal chemotherapy significantly improves survival among women with advanced ovarian cancer; however, fewer than half of eligible U.S. patients are receiving it, according to research published online ...

Recommended for you

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Study finds gut microbiome can control antitumor immune function in liver

May 24, 2018
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published May 25 in Science, was led by researchers in the Center for Cancer Research (CCR) at the National ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.